ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1562	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	cancer treatment 0.321266 high-dose radiation therapy 0.323579 centimeters 0.269921 cancer spreads 0.270417 malignant tumor cells 0.281954 body 0.305644 chemotherapy 0.290118 PDQ cancer information 0.346817 stage III hypopharyngeal 0.274417 clinical trial search 0.347149 clinical trials 0.698171 hypopharynx 0.280224 cancer information summary 0.319294 metastatic hypopharyngeal cancer 0.310093 clinical trial 0.551798 Recurrent hypopharyngeal cancer 0.306668 patients 0.317052 stage IV hypopharyngeal 0.274937 nearby soft tissue 0.271159 treatment clinical trial 0.275593 NCI PDQ cancer 0.283768 radiation therapy 0.705932 Treatment Editorial Board 0.281401 General information 0.289657 hypopharyngeal cancer 0.722179	general cancer information 0.275426 treatment 0.442202 new cancer treatments 0.272872 NCI-supported cancer 0.296123 cancer cells 0.361641 Cancer Information Service 0.276024 patient 0.26688 lymph nodes 0.350794 treatment clinical trials 0.300384 National Cancer Institute 0.364736 swollen lymph nodes 0.277694 new treatment 0.302418 External radiation therapy 0.314938 neck 0.309398 cancer research process 0.269057 cancer clinical trials 0.358746 stage 0.310003 neck cancer 0.286172 lymph node 0.322344 cancer information summaries 0.27414 comprehensive cancer information 0.274558 cancer 0.901171 standard treatment 0.274055 Hypopharyngeal Cancer Treatment 0.314822	CLICK HERE
1664	National Cancer Institute	Html	en	Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors	cancer treatment 0.542006 metastatic brain tumors 0.391418 ongoing clinical trials 0.389415 PDQ cancer information 0.511527 tumor suppressor genes 0.452709 clinical trial search 0.399694 brain tumors 0.444671 CNS atypical teratoid/rhabdoid 0.388691 clinical trials 0.847224 Pediatric Treatment Editorial 0.416481 Teratoid/Rhabdoid Tumor Treatment 0.445097 cancer information summary 0.463674 clinical trial 0.521041 cancer cells 0.510172 stem cell transplant 0.396934 patients 0.411179 primary brain tumors 0.3918 treatment clinical trial 0.409064 NCI PDQ cancer 0.42324 radiation therapy 0.555658 Treatment Editorial Board 0.420841 Cord Tumors Treatment 0.414346 late effects 0.393798 treatment 0.689522 new cancer treatments 0.395428	PDQ treatment summary 0.447943 childhood brain 0.385451 Cancer Information Service 0.399251 specific cancer cells 0.397642 PDQ Pediatric Treatment 0.40786 treatment clinical trials 0.444124 National Cancer Institute 0.458723 spinal cord 0.616147 tumor cells 0.437516 effects cancer treatment 0.421518 new treatment 0.427513 childhood cancer information 0.400212 External radiation therapy 0.395094 brain tumor 0.405279 brain 0.467984 atypical teratoid/rhabdoid tumor 0.982554 PDQ summary 0.439127 cancer clinical trials 0.434177 cancer information summaries 0.39809 comprehensive cancer information 0.397631 cancer 0.740574 appropriate cancer treatment 0.419383 standard treatment 0.391688 fast-growing tumor 0.388774	CLICK HERE
1670	National Cancer Institute	Html	en	Oral Cavity and Oropharyngeal Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for oral cancer.	cancer treatment 0.462069 cancer screening methods 0.510918 ongoing clinical trials 0.459171 following PDQ summaries 0.498704 PDQ cancer information 0.601619 squamous cells 0.461192 Oropharyngeal cancer forms 0.542461 clinical trials 0.552349 test result 0.478895 cancer information summary 0.545028 clinical trial 0.464502 breast cancer prevention 0.475292 fluorescent mouth rinse 0.459409 PDQ Oral Cavity 0.538179 cancer patients 0.455495 latest published information 0.461223 Oropharyngeal Cancer Prevention 0.539186 NCI’s PDQ 0.469112 cancer symptoms 0.470328 NCI PDQ cancer 0.519444 tests 0.472016 certain types 0.45905 Oral cavity cancer 0.562303 PDQ Screening 0.487794	treatment 0.479473 abnormal tissue 0.496498 screening tests 0.460194 oropharyngeal cancers 0.542436 Cancer Information Service 0.4864 Prevention Editorial Board 0.494212 treatment clinical trials 0.460544 National Cancer Institute 0.552754 PDQ documents 0.4638 new treatment 0.461424 Cancer screening trials 0.51442 oropharyngeal cancer screening 0.581362 Cancer Care page 0.477739 PDQ database 0.466412 PDQ summary 0.507494 cells 0.483262 abnormal red patch 0.460863 abnormal white patch 0.460254 cancer information summaries 0.491365 oral cavity 0.970425 comprehensive cancer information 0.49122 cancer 0.792804 oropharyngeal cancer 0.758721 early stage 0.462272	CLICK HERE
1817	National Cancer Institute	Html	es	Tratamiento del neuroblastoma (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del neuroblastoma.	proteína mycn 0.336322 International Neuroblastoma 0.628182 International Neuroblastoma Risk 0.447509 Internacional Neuroblastoma Staging 0.44498 Sin embargo 0.822701 Internacional Neuroblastoma 0.565858 neuroblastoma chd5 0.470002 largo plazo 0.351143 presuntos tumores 0.343323 Risk Group Project 0.315769 high-risk neuroblastoma 0.457856 anomalía cromosómica 0.341006 proteínas myc 0.40081 receptor tipo 0.334046 Group Staging System 0.316719 siguientes genes 0.322225 Macmillan Publishers Ltd 0.319163 cinasa alk 0.340921 Neuroblastoma Pathology Classification 0.578931 presumible neuroblastoma 0.448924 adultos jóvenes 0.346234 Children’s Oncology Group 0.362343 gen alk 0.512613 siguientes tipos 0.316031 estadio 4 0.468918	alargamiento alternativo 0.316851 riesgo intermedio 0.515053 efectos tardíos 0.336486 PDQ Efectos tardíos 0.326203 escasa expresión 0.31757 ensayo clínico alemán 0.317939 Risk Group 0.325182 supuesto gen 0.321026 ploidy or mycm 0.321186 tumores hiperdiploides 0.348329 gen tert 0.322687 PDQ Tratamiento 0.315838 características histológicas 0.911452 International Neuroblastoma Pathology 0.574297 site or frameshit 0.320313 pronóstico adverso 0.322402 asimismo mutaciones 0.347925 cromosómicas segmentarias versus 0.354412 sección mutaciones 0.348351 mutaciones activadoras 0.395132 Internacional Neuroblastoma Group 0.477285 Staging System 0.328084 anticuerpo anti-GD2 0.335718 mecanismos genéticos aberrantes 0.321444	CLICK HERE
1883	National Cancer Institute	Html	es	Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.	cell tumor protocols 0.408279 germinativas malignas localización 0.405353 células germinativas seminomatosos.Seminoma 0.410393 cell tumor combined 0.407867 germ cell tumours 0.412186 Perlman EJ 0.405253 Calaminus G 0.412513 Cell Cancer Collaborative 0.406794 cell tumors from 0.406747 Göbel U 0.406021 Cancer Group 0.42074 cell tumor studies 0.407558 pediatric oncology 0.41388 células germinativas mixtos 0.417539 International Germ Cell 0.417008 Children's Oncology Group 0.409014 mediastinal germ 0.406328 cell tumor study 0.408368 <2 cm 0.405406 Metástasis peritoneales macroscópicas 0.405941 germ cell neoplasms 0.406391 Children's Cancer 0.42175 cell tumors show 0.406094 pediatric germ 0.426106 adultos jóvenes 0.40725	estadio iv 0.405826 ganglios linfáticos ≥2 0.411723 Germ Cell Consensus 0.412507 Cushing B 0.405386 teratomas benignos 0.407141 Genes Chromosomes Cancer 0.438953 with germ 0.406335 malignant germ cell 0.462527 PDQ Tratamiento 0.405882 childhood germ 0.409831 cell tumors based 0.405903 Clin Oncol 0.444548 saco vitelino 0.435575 linfáticos ≥2 cm 0.408554 Schneider DT 0.409517 Children's Cancer Group 0.419331 Cell Consensus Classification 0.409901 germ cell tumors 0.974328 Kingdom Children Cancer 0.408316 germ cell cancer 0.410294 Children's Cancer Study 0.409136 pediatric oncology group 0.410202 oncology group 0.420408 Cancer Study Group 0.411644	CLICK HERE
2000	National Cancer Institute	Html	es	Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.	cuánto aire 0.415134 siguientes procedimientos 0.528715 células madre 0.858073 adultos jóvenes 0.464664 efectos secundarios meses 0.439126 siguientes aspectos 0.434701 faja ajustadora 0.428231 HCL infantil multisistémica 0.546722 cuántos sistemas 0.518567 genes ras 0.453948 pequeña cantidad 0.423844 células normales.ampliar exploración 0.532323 vía oral 0.42013 rayos x 0.425227 gen braf 0.666188 largo plazo 0.44968 cuántas células 0.518957 niño ayuda 0.426203 efectos tardíos 0.516221 escáner.ampliar exploración 0.429231 tarde.ampliar ecografía 0.427113	vías respiratorias 0.424871 causa problemas 0.424997 lesiones óseas 0.423193 National Cancer Institute 0.417904 IRMN).Ampliar Imágenes 0.421648 siguientes riesgos 0.415861 radiación uvb 0.414555 Instituto Nacional 0.431398 PDQ Tratamiento 0.451873 antecedentes familiares 0.589915 llamada genes ras 0.432872 explorador tep 0.430081 terapia fotodinámica causa 0.453098 sistema nervioso central 0.604707 Physician Data Query 0.464236 mayores probabilidades 0.416225 HCL multisistémica 0.966875 terapia fotodinámica llamada 0.451949 radiación ultravioleta 0.561342 siguientes pruebas 0.489919	CLICK HERE
3900	National Cancer Institute	Html	en	Public Health Service Act	Information on the Public Health Service Act and related legislation that directly impacted the mission of NCI.	future NIH reorganizations 0.419512 Human Services 0.393504 Biomedical Research Panel 0.846998 biomedical research program 0.579792 American merchant seamen 0.370969 national research institutes 0.416708 recent Administration record 0.353386 NIH reporting requirements 0.42538 National Institutes 0.458558 President’s Cancer 0.359747 cancer patients 0.397757 scientific peer review 0.364817 class cancer care 0.399826 Reduced minimum number 0.342577 National Cancer Program. 0.421335 new Comprehensive Cancer 0.408225 NCI 0.391469 National Cancer Act 0.681476 Scientific Management Review 0.343953 National Cancer Program 0.508981 Cancer Panel meetings 0.406859 President’s Biomedical 0.473241 occupation carcinogenesis research 0.398948 NIH resources 0.361136 International Cancer Research 0.440008	national cancer 0.744834 intensified research program 0.423987 basic research laboratory 0.420967 cancer communication activities 0.401446 information dissemination programs 0.354532 Rep. Joe Barton 0.339975 committee 0.46056 national cancer control 0.4441 Committee Report No. 0.405931 Medical Facilities Construction 0.355248 NCI Director 0.348101 NIH research activities 0.511683 NIH director 0.411073 NIH 0.520603 new authorizing language 0.385653 cancer centers 0.388024 Health Service Act 0.762452 cancer control mandate 0.391408 program coordination 0.359566 Public Health Service 0.988569 research contracts 0.341664 research programs 0.355014 control activities research 0.408316 exfoliative cytology tests 0.366574	CLICK HERE
4338	National Cancer Institute	Html	en	Memory or Concentration Problems and Cancer Treatment	Cancer treatments, such as chemo, may cause difficulty thinking, concentrating, or other cognitive problems. Learn about steps people with cancer can take to manage these side effects. See a list of helpful questions for families to ask the doctor.	cognitive problems 0.80867 cancer treatment 0.62932 phone numbers 0.602305 occupational therapists 0.593535 questions 0.471687 family member 0.916079 type 0.442055 greater memory 0.624849 chemotherapy 0.446122 health care team 0.805887 poor nutrition 0.618951 electronic device 0.597541 things 0.6294 small changes 0.62165 social worker 0.598295 daily planner 0.596862 biological therapies 0.636385 mental exercises 0.597838 important information 0.613471 night 0.47682 chemo brain 0.652554 list 0.545178 steps 0.478481 symptoms 0.475521 radiation therapy 0.635339	minor memory 0.611151 bit more difficulty 0.644087 additional support 0.600444 short naps 0.667478 mental fog 0.64322 light physical exercises 0.781082 health-related factors 0.640365 Mind–body practices 0.607504 vocational therapists 0.597413 Exercise releases endorphins 0.792537 concentration problems 0.963343 Long naps 0.655178 feel-good chemicals 0.628223 daily routine 0.619747 types 0.441521 Cancer treatments 0.637599 cognitive changes 0.602139 important activities 0.605353 neuropsychologists 0.454252 people 0.518089 doctor 0.475116 help 0.443453 important names 0.60441 extra rest 0.613564	CLICK HERE
15640	National Cancer Institute	Html	null	Research & Development (R&D) Contracts	null			CLICK HERE
16600	National Cancer Institute	Html	en	Aspirin to Reduce Cancer Risk	A federal advisory panel supports aspirin to reduce the risk of colorectal cancer, while researchers are investigating whether it may help reduce the risk of other cancers.	high-dose daily aspirin 0.674804 colorectal cancer prevention 0.571738 USPSTF chair Kirsten 0.487385 long-term aspirin 0.663026 Dr. Umar 0.469811 University Comprehensive Cancer 0.508256 recent Harvard study 0.46976 colorectal cancer risk 0.79898 task force 0.503648 Harvard Medical School 0.473077 clinical trials 0.598455 colorectal cancer screening 0.565807 observational studies 0.495177 long-running cohort studies 0.481808 Cancer Center 0.506614 reduced risk 0.481524 colorectal cancer 0.931694 ovarian cancer 0.471756 Nature Reviews Cancer 0.518208 aspirin group 0.617639 low-dose aspirin 0.665023 gastrointestinal cancer 0.48385 Dr. Hawk 0.575018 federal advisory panel 0.47098 randomized clinical trials 0.478512	colorectal cancers 0.549284 Dr. Brasky 0.505177 cancer type 0.471148 U.S. Preventive Services 0.472306 heart attack 0.471676 longer-term aspirin 0.60828 cancer prevention 0.597763 United States 0.478678 aspirin’s inhibition 0.619167 interval cancer rate 0.501859 pancreatic cancer 0.472024 Cancers Research Group 0.481416 aspirin 0.98518 studies 0.539154 different aspirin doses 0.642633 cardiovascular disease 0.514113 MD Anderson Cancer 0.5105 Dana-Farber Cancer Institute—using 0.498216 regular aspirin 0.76763 people 0.473586 lump aspirin 0.623949 average colorectal cancer 0.575376 JAMA Oncology 0.46922 cancers—participants given aspirin 0.673562	CLICK HERE